PHIA Koninklijke Philips N.V.

Philips Foundation and RAD-AID International embark on a multi-year cross-continental partnership to increase access to ultrasound services for 50 million people in low- and middle-income countries

Philips Foundation and RAD-AID International embark on a multi-year cross-continental partnership to increase access to ultrasound services for 50 million people in low- and middle-income countries

September 13, 2022

  • Philips Foundation and RAD-AID International leverage Philips’ expertise in mobile ultrasound services to improve access to virtual care in hard-to-reach areas
  • New partnership sets up intensive program in 10 countries to train a wide range of health workers and specialists through real-time distance education and simulated procedure demonstrations
  • Co-created program aims to reach 50 million people by deploying hundreds of ultrasound devices that allow for remote healthcare thousands of kilometers away

 Amsterdam, the Netherlands – , with its mission to provide access to quality healthcare for 100 million people a year in underserved communities by 2030, together with Philips and RAD-AID International, today announced a multi-year cross-continental partnership to promote access to diagnostic ultrasound services in ten countries.

, a US-based non-profit organization, will leverage the virtual care capabilities of Philips ultrasound solutions to provide a highly scalable, remote ‘train-the-trainer’ model to improve access to diagnostic and point-of-care ultrasound through curriculum-based education and clinical hands-on teaching. With these solutions, ultrasound experts, such as radiologists and sonographers, can communicate with training program participants thousands of kilometers away via voice, video and text messages, view the ultrasound images taken in real time, and remotely demonstrate equipment settings during guided ultrasound exams if necessary.

“By adopting a ‘train-the-trainer’ model, first-generation healthcare workers can contribute to the education of the next generation of ultrasound practitioners,” said Daniel J. Mollura, President and CEO of RAD-AID International. “This innovative and ambitious initiative has a remarkable reach, and is both sustainable and scalable. We at RAD-AID look forward to working with the Philips Foundation in the coming years to improve the lives of millions of people through real-time ultrasound education and remote support.”

“Despite the well-known benefits of early detection and timely treatment, diagnostic imaging is not available in many rural and remote areas where resources are scarce,” said Margot Cooijmans, Director of the Philips Foundation. “Through this collaboration with RAD-AID International, who provide a high quality of service delivery, we can offer equipment and enable remote training in ten underserved areas, with a clear focus on increasing the number of patients who benefit from remote access to professional radiologists. Enhancing technology to improve healthcare for underserved populations defines this collaboration and is at the heart of our mission.”

Philips Foundation, Philips and RAD-AID International all have a track record of improving access to ultrasound by training local health workers. For example, in recent years, solutions. Together with healthcare experts, non-governmental organizations, and social entrepreneurs, it has pioneered task-sharing models and explored aspects such as delivery, referral, and income models to enable access to ultrasound for prenatal care. Philips innovates in connected care solutions that support healthcare systems and improve access to care for millions of people across the world. The company that link specialists around the globe with local physicians in underserved communities to train them and enable them to provide potentially life-saving ultrasound scans to pregnant women.



This multi-year initiative aims to reach around 50 million people across Africa, Asia, North America, Latin America, and the Caribbean, including Ethiopia, Ghana, Grenada, Guyana, Kenya, Laos, Nepal, Malawi, Tanzania, and the US. During the project’s initial phase, RAD-AID International is deploying the model in the first five high-impact regional sites. Learnings from phase-one deployment will help Philips Foundation and RAD-AID International co-create new educational strategies for second-phase deployment.

For further information, please contact:

Joost Maltha 

Philips Global Press Office 

Tel: +31 6 10 55 8116  

E-mail: 

Yannick Eshuijs

Philips Foundation

Tel.:

E-mail:

Daniel J. Mollura

RAD-AID International

E-mail:  

About Philips Foundation

Philips Foundation is a registered non-profit organization established in 2014 – with a mission to provide access to quality healthcare for underserved communities across the globe. By leveraging Philips’ capabilities and combining them with the experience and expertise of non-governmental organizations and other community-focused and impact-driven enterprises, Philips Foundation helps create innovative pathways to open up affordable healthcare for communities most in need. By also partnering with innovative social entrepreneurs rooted in the local ecosystem, Philips Foundation aims to increase access to healthcare for 100 million people a year by 2030. More information can be found at

About Royal Philips

Royal Philips (NYSE: PHG, AEX: PHIA) is a leading health technology company focused on improving people’s health and well-being, and enabling better outcomes across the health continuum – from healthy living and prevention, to diagnosis, treatment and home care. Philips leverages advanced technology and deep clinical and consumer insights to deliver integrated solutions. Headquartered in the Netherlands, the company is a leader in diagnostic imaging, image-guided therapy, patient monitoring and health informatics, as well as in consumer health and home care. Philips generated 2021 sales of EUR 17.2 billion and employs approximately 78,000 employees with sales and services in more than 100 countries. News about Philips can be found at

About RAD-AID

RAD-AID International is a non-profit (501c3) charitable organization with the mission of increasing and improving radiology and medical imaging for medically underserved regions. RAD-AID delivers radiology education and training through on-site and hands-on teaching of healthcare workers in low and middle-income countries (LMICs), as well as low-resource facilities in medically underserved communities of high-income countries. RAD-AID designs, builds, and implements healthcare infrastructure, imaging equipment, and radiology technology, integrated with clinical training, to accomplish vital radiology capacity-building. The organization consists of over 15,000 volunteers and 85 university-based medical center chapters and operates global health outreach programs in 40 countries across Africa, Asia, the South Pacific, and Latin America and the Caribbean. As radiology is vital to most health services, such as cancer treatment, maternal-fetal monitoring, heart disease care, and trauma response, RAD-AID improves the accessibility, safety, and quality of radiology worldwide as an anchor for improving global health. Learn more at



 



EN
13/09/2022

Underlying

To request access to management, click here to engage with our
partner Phoenix-IR's CorporateAccessNetwork.com

Reports on Koninklijke Philips N.V.

 PRESS RELEASE

Philips agrees to acquire SpectraWAVE Inc., advancing next-generation ...

Philips agrees to acquire SpectraWAVE Inc., advancing next-generation coronary intravascular imaging and physiological assessment with AI December 15, 2025 Acquisition of SpectraWAVE’s next-generation technologies including HyperVueTM Imaging System with Enhanced Vascular Imaging for comprehensive, rapid, and AI-supported imaging inside the coronary arteries, and X1TM-FFR, an AI-enabled angio-based FFR technology that delivers rapid, accurate coronary physiology assessment from a single angiogram [1] SpectraWAVE’s technologies have the potential to significantly increase adoption of corona...

 PRESS RELEASE

Philips reiterates timing of 2026 outlook

Philips reiterates timing of 2026 outlook December 4, 2025 Amsterdam, the Netherlands – (NYSE: PHG, AEX: PHIA), a global leader in health technology, today reaffirmed that its 2026 outlook will be issued as planned on February 10, in line with the company’s previously communicated schedule. As previously guided, the company expects continued performance improvement with sequential comparable sales growth, expanded margins (despite tariff headwinds) and strong cashflow. The company continues to expect comparative sales growth to accelerate sequentially in 2026 towards mid-single-digit gro...

 PRESS RELEASE

Philips expands commercial availability of world’s first real-time AI-...

Philips expands commercial availability of world’s first real-time AI-enabled light-based 3D navigation solution for image-guided therapy December 1, 2025 Commercial availability expanded across Europe and the United StatesReal-time AI-enabled 3D device visualization powered by light instead of X-ray, improving navigation in complex endovascular proceduresLumiGuide seamlessly integrates with Azurion, Philips’ proven, world-leading image-guided therapy platform designed to drive procedural innovation across clinical domains Amsterdam, the Netherlands and Chicago, USA – (NYSE: PHG, AEX: PH...

 PRESS RELEASE

Philips launches Verida, world’s first detector-based spectral CT powe...

Philips launches Verida, world’s first detector-based spectral CT powered by breakthrough AI, to advance diagnostic precision November 30, 2025 Philips pioneered detector-based spectral CT, which has been widely adopted in clinical routine exams across anatomies, supported by over 800 peer-reviewed publications [1]CE-marked, 510k pending Verida CT [2] integrates AI across the imaging chain, providing superb image quality while accelerating workflow and reducing dose [3, 4] Amsterdam, the Netherlands and Chicago, USA – At RSNA 2025, (NYSE: PHG, AEX: PHIA), a global leader in health techno...

 PRESS RELEASE

Philips unveils BlueSeal Horizon, industry’s first helium-free 3.0T MR...

Philips unveils BlueSeal Horizon, industry’s first helium-free 3.0T MRI platform November 30, 2025 Major technology breakthrough combines advanced AI for clinical insights and accelerated workflow in new premium 3.0T MRI platform [1] Amsterdam, the Netherlands, and Chicago, USA – (NYSE: PHG, AEX: PHIA), a global leader in health technology, today unveiled BlueSeal Horizon [1], an entirely new 3.0T MRI innovation platform that includes the industry’s first helium-free 3.0T magnet at . A pivotal advance in MRI innovation, helium-free [2] 3.0T is a major scientific achievement set to have s...

ResearchPool Subscriptions

Get the most out of your insights

Get in touch